Skip to content
Cartherics Logo Cartherics Logo
  • Our Company
    • About Us
    • Our Vision & Mission
    • Founders
    • Board Members & Key Executives
    • Scientific Consultants
    • Partners & Collaborations
    • Our Lab
  • Technology
    • Our Technology
  • Pipeline
    • Our Pipeline
    • Scientific Publications
    • Scientific & Company Presentations
  • Careers
    • Careers at Cartherics
    • Education Opportunities
  • Latest News
  • Investors
  • Contact Us

Latest News

Home » Latest News
Latest Newscarth_admin2026-06-02T11:12:27+10:00
  • Categories: General

    Flow cytometry: The core characterisation technique for developing next-generation cancer immunotherapies

    Published On: August 28th, 2019

    CAR-T immunotherapy involves genetically engineering T-cells with chimeric antigen receptors (CARs). FLOW cytometry uses antibodies tagged with fluorescent markers that [...]

    Read More
  • Categories: General

    Monash University Student Open Day

    Published On: August 27th, 2019

    A student development evening was held again this year on 26 August 2019 at Monash University Clayton where Professor Graham [...]

    Read More
  • Categories: General

    Can an immune strategy used to treat cancer also wipe out HIV infections?

    Published On: August 12th, 2019

    Drugs work stunningly well to control HIV—but not in everyone, and not without side effects. That's why a small cadre [...]

    Read More
  • Categories: General Investor News

    Clinical Trials Bite Off Chunk of CAR T Therapy Market

    Published On: August 6th, 2019

    https://www.the-scientist.com/news-opinion/clinical-trials-bite-off-chunk-of-car-t-therapy-market-66212 About a quarter of lymphoma patients eligible for the cancer treatments are opting for experimental—and free—options instead. Jul 30, [...]

    Read More
  • Categories: General Investor News

    CAR-T Cell Cancer Therapy to Save Lives (Media Release)

    Published On: August 5th, 2019

    https://www.premier.vic.gov.au/car-t-cell-cancer-therapy-to-save-lives/ The Victorian and Commonwealth Governments work together to make CAR-T Cell Therapy available to patients CAR-T Cell Therapy is [...]

    Read More
  • Categories: General Investor News

    Australian Actor Tom Long cancer-free after medical trial

    Published On: July 29th, 2019

    The Age, 28 July 2019 By Melissa Cunningham Former SeaChange actor Tom Long was on the brink of death when [...]

    Read More
  • Categories: General The Pipeline

    Cartherics’ research team just got bigger

    Published On: July 18th, 2019

    As of July, the number of scientists sharing the work load in Cartherics’ laboratory hit an even dozen.  That’s thanks [...]

    Read More
  • Categories: General Investor News

    Patent office reopens major CRISPR battle between Broad Institute and Univ. of California

    Published On: July 3rd, 2019

    STAT Biotech - By Sharon Begley @sxbegle JUNE 25, 2019 The U.S. patent office has declared an interference between a dozen [...]

    Read More
  • Categories: General

    Cartherics shareholders Thao and Luyen Nguyen at the June 2019 Board Meeting …….

    Published On: June 24th, 2019

    Cartherics shareholders Thao and Luyen Nguyen at the June 2019 Board Meeting with Cartherics Chairman Bob Moses and CEO Alan Trounson celebrating [...]

    Read More
  • Categories: General The Pipeline

    Australian Biotechnology “REALITIES” : From the Laboratory to the Marketplace

    Published On: June 7th, 2019

    Cartherics’ Chairman Bob Moses has over 40 years of executive experience in life science companies. You name it, he’s been [...]

    Read More
  • Categories: General Investor News

    Science and Technology priorities – Election 2019

    Published On: May 8th, 2019

    MEDIA RELEASE 8 May 2019 Parties use science to set themselves apart .... The major parties have laid out their science [...]

    Read More
  • Categories: Conferences General

    Save the date : 25-27 March 2020 Eradicate Cancer, next frontiers in immunotherapy

    Published On: May 3rd, 2019

    http://www.eradicatecancer2020.org

    Read More
  • Categories: Conferences General

    Save the date : 25-27 March 2020 Eradicate Cancer, next frontiers in immunotherapy

    Published On: May 3rd, 2019

    http://www.eradicatecancer2020.org

    Read More
  • Categories: General

    The Next Frontier of CAR-T Cell Therapy: Solid Tumors

    Published On: April 4th, 2019

    The Technology has wowed the field by all but obliterating some patients' blood cancers, but sold malignancies present new challenges [...]

    Read More
  • Categories: General

    Miracle Elixirs

    Published On: April 4th, 2019

    A long way into the quest to vanquish cancer, our ears strain to hear the words, “Cancer is cured”- a [...]

    Read More
Previous121314Next
  • Our Company
  • Technology
  • Pipeline
  • Latest News
  • Investors

12 Ferntree Place
Notting Hill VIC 3168
AUSTRALIA

info@cartherics.com

+61 1300 973 415

About us

Cartherics’ mission is the development of novel, immune cell therapy products for the treatment of cancer and endometriosis.

Sign up to our newsletter

Stay informed about our latest news and developments

* indicates required


© Copyright 2022 – 2026| Cartherics Pty Ltd

Page load link

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Cartherics
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Go to Top